EP Patent

EP2019105A1 — Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives

Assigned to Siegfried AG · Expires 2009-01-28 · 17y expired

What this patent protects

The present invention relates to a process for the preparation of quaternary N-alkyl morphin or morphinan alkaloid derivatives of general formula (I) a or b wherein A is -C(O)-, -C(S)-, -C(=CH 2 )-, or -CHA 1 -, R 1 is hydrocarbyl or substituted hydrocarbyl, R 2 is hyd…

USPTO Abstract

The present invention relates to a process for the preparation of quaternary N-alkyl morphin or morphinan alkaloid derivatives of general formula (I) a or b wherein A is -C(O)-, -C(S)-, -C(=CH 2 )-, or -CHA 1 -, R 1 is hydrocarbyl or substituted hydrocarbyl, R 2 is hydrocarbyl or substituted hydrocarbyl, preferably selected from substituted or unsubstituted, saturated or unsaturated compounds of from 1 to 8 carbons; X - is an anion, Y is hydrogen, hydroxy, alkoxy, or acyloxy. This is achieved by using a nucleophilic nitrogen, phosphor or sulfur, containing base in the reaction mixture.

Drugs covered by this patent

Patent Metadata

Patent number
EP2019105A1
Jurisdiction
EP
Classification
Expires
2009-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Siegfried AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.